Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Demyelinating disorders, characterized by a chronic or episodic destruction of the myelin sheath, are a leading cause of neurological disability in young adults in western countries. Studying the complex mechanisms involved in axon myelination, demyelination and remyelination requires an experimental model preserving the neuronal networks and neuro-glial interactions. Organotypic cerebellar slice cultures appear to be the best alternative to in vivo experiments and the most commonly used model for investigating etiology or novel therapeutic strategies in multiple sclerosis. Areas covered: This review gives an overview of slice culture techniques and focuses on the use of organotypic cerebellar slice cultures on semi-permeable membranes for studying many aspects of axon myelination and cerebellar functions. Expert opinion: Cerebellar slice cultures are probably the easiest way to faithfully reproduce all stages of axon myelination/demyelination/remyelination in a three-dimensional neuronal network. However, in the cerebellum, neurological disability in multiple sclerosis also results from channelopathies which induce changes in Purkinje cell excitability. Cerebellar cultures offer easy access to electrophysiological approaches which are largely untapped and we believe that these cultures might be of great interest when studying changes in neuronal excitability, axonal conduction or synaptic properties that likely occur during multiple sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remyelination in the CNS: from biology to therapy
Franklin, R. J. M., & ffrench-Constant, C. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2480 · Cited by 1,544 · cited 1×
“differentiation into mature myelinating oligodendrocytes [98].”
Altman, J. (1972) · Journal of Comparative Neurology · doi:10.1002/cne.901450402 · Cited by 996 · cited 1×
“This migration of Purkinje cells is accompanied by the development of their dendritic tree [52] and later, by the myelination of their axon by oligodendrocytes [53].”
BackgroundA patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine
Fenwick, E. M., Marty, A., & Neher, E. (1982) · The Journal of Physiology · doi:10.1113/jphysiol.1982.sp014393 · Cited by 812
Microglia Promote the Death of Developing Purkinje Cells
Marı́n-Teva, J. L., Dusart, I., Colin, C., Gervais, A., van Rooijen, N., & Mallat, M. (2004) · Neuron · doi:10.1016/s0896-6273(04)00069-8 · Cited by 757 · cited 2×
“Notably, it remains to be established whether treatments that improve the survival of developing Purkinje cells [76,77,107] also protect mature Purkinje cells.”
BackgroundOrganotypic brain slice cultures: A review
Humpel, C. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.07.086 · Cited by 480
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo
Najm, F. J., Madhavan, M., Zaremba, A., Shick, E., Karl, R. T., Factor, D. C., Miller, T. E., Nevin, Z. S., Kantor, C., Sargent, A., et al. (2015) · Nature · doi:10.1038/nature14335 · Cited by 424
Raman, I. M., Sprunger, L. K., Meisler, M. H., & Bean, B. P. (1997) · Neuron · doi:10.1016/s0896-6273(00)80969-1 · Cited by 390
Mi, S., Miller, R. H., Tang, W., Lee, X., Hu, B., Wu, W., Zhang, Y., Shields, C. B., Zhang, Y., Miklasz, S., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21581 · Cited by 300 · cited 2×
“tors, respectively [102], or antagonists of Lingo-1 [103].”
BackgroundGut Microbiota: The Brain Peacekeeper
Mu, C., Yang, Y., & Zhu, W. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00345 · Cited by 188 · cited 6×
“In rodents affected with experimental autoimmune encephalomyelitis (model of MS in rodents), the administration of Na+ channel blockers (phenytoin, flecainide, or lamotrigine) could reduce axon degeneration in the CNS [111–114].”
BackgroundInfluentialCell death and proliferation in acute slices and organotypic cultures of mammalian CNS
Lossi, L., Alasia, S., Salio, C., & Merighi, A. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.002 · Cited by 141
Cited by
In vitro Models of Neurodegenerative Diseases
Slanzi, A., Iannoto, G., Rossi, B., Zenaro, E., & Constantin, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00328 · Cited by 290
Quintela-López, T., Ortiz-Sanz, C., Serrano-Regal, M. P., Gaminde-Blasco, A., Valero, J., Baleriola, J., Sánchez-Gómez, M. V., Matute, C., & Alberdi, E. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1636-8 · Cited by 80
An overall view of the most common experimental models for multiple sclerosis
Dedoni, S., Scherma, M., Camoglio, C., Siddi, C., Dazzi, L., Puliga, R., Frau, J., Cocco, E., & Fadda, P. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106230 · Cited by 79
Advanced in vitro models: Microglia in action
Cakir, B., Kiral, F. R., & Park, I.-H. (2022) · Neuron · doi:10.1016/j.neuron.2022.10.004 · Cited by 32
(2022) · Methods in Cell Biology · doi:10.1016/bs.mcb.2021.12.011 · Cited by 8
Metadata
- Authors
- Doussau, F., Dupont, J.-L., Neel, D., Schneider, A., Poulain, B., & Bossu, J. L.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2017-07-20
- Volume
- 12
- Issue
- 10
- Pages
- 1011-1022
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2734577709
- Cited by
- 49
- References
- 12
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders. https://app.cochat.ai/papers/10.1080/17460441.2017.1356285
- The paper
- Doussau, F., Dupont, J.-L., Neel, D., Schneider, A., Poulain, B., & Bossu, J. L. (2017). Organotypic cultures of cerebellar slices as a model to investigate demyelinating disorders. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2017.1356285
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.